(Q50015039)

English

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.

scientific article published on 14 February 2018

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29442540

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

clinical oncology

1 reference

based on heuristic

inferred from title

Jeffrey S Weber

27

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

National Comprehensive Cancer Network

30

object named as

National Comprehensive Cancer Network

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Jedd D. Wolchok

28

object named as

Jedd D Wolchok

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Loretta J Nastoupil

17

object named as

Loretta J Nastoupil

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

author name string

Julie R Brahmer

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Christina Lacchetti

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Bryan J Schneider

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Michael B Atkins

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Kelly J Brassil

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Jeffrey M Caterino

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Ian Chau

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Marc S Ernstoff

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Jennifer M Gardner

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Pamela Ginex

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Sigrun Hallmeyer

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Jennifer Holter Chakrabarty

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Natasha B Leighl

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Jennifer S Mammen

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

David F McDermott

15

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Tanyanika Phillips

18

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Laura D Porter

19

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Igor Puzanov

20

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Cristina A Reichner

21

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Bianca D Santomasso

22

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Carole Seigel

23

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Alexander Spira

24

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Maria E Suarez-Almazor

25

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Yinghong Wang

26

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

John A Thompson

29

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Aung Naing

16

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

language of work or name

0 references

publication date

14 February 2018

1 reference

Europe PubMed Central

PubMed publication ID

23 February 2018

http://europepmc.org/abstract/MED/29442540

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

36

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

17

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

1714-1768

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Case reports of heart failure after therapy with a tumor necrosis factor antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II study of ipilimumab for patients with metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ipilimumab: controversies in its development, utility and autoimmune adverse events

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advances in the understanding of acquired haemophilia A: implications for clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab for the treatment of refractory scleritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe interstitial pneumonitis associated with the administration of taxanes

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How I treat patients with thrombotic thrombocytopenic purpura: 2010

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemophilia A induced by ipilimumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

More on hemophilia A induced by ipilimumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic and therapeutic challenges of acquired thyrotropic deficiency.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of immune-related adverse events and kinetics of response with ipilimumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-cytotoxic T-cell lymphocyte antigen-4-induced regression of spinal cord metastases in association with renal failure, atypical pneumonia, vision loss, and hearing loss.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The risk of rash associated with ipilimumab in patients with cancer: a systematic review of the literature and meta-analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Organizing pneumonia as a side effect of ipilimumab treatment of melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exposure-response relationships of the efficacy and safety of ipilimumab in patients with advanced melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Update on the use of systemic biologic agents in the treatment of noninfectious uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Opportunistic infections in patients treated with immunotherapy for cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving immunotherapy and its association with survival: a systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How I treat refractory thrombotic thrombocytopenic purpura

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pembrolizumab versus Ipilimumab in Advanced Melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pembrolizumab for the treatment of non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicities of Immunotherapy for the Practitioner

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late onset ipilimumab-induced pericarditis and pericardial effusion: a rare but life threatening complication

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Managing immune checkpoint-blocking antibody side effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correction to Lancet Oncol 2015; 16: 522-30. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thyroid function in critically ill patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systematic review: colitis associated with anti-CTLA-4 therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of gastrointestinal complications in cancer patients treated with immune checkpoint inhibitors: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Understanding Immune Checkpoint Inhibitors for Effective Patient Care

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune checkpoint inhibitors in clinical practice: update on management of immune-related toxicities

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical, Endoscopic, and Histologic Characteristics of Ipilimumab-Associated Colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Checkpoint Inhibitors in Kidney Transplant Recipients and the Potential Risk of Rejection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune-related adverse events with immune checkpoint blockade: a comprehensive review

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of toxicities of immune checkpoint inhibitors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Left Ventricular Dysfunction After Treatment With Ipilimumab for Metastatic Melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of pneumonitis in cancer patients treated with immune checkpoint inhibitors: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor Regression and Allograft Rejection after Administration of Anti-PD-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy-Associated Hemolytic Anemia with Pure Red-Cell Aplasia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of the PD-1 Pathway Inhibitor Nivolumab in a Renal Transplant Patient With Malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy and safety of nivolumab in the treatment of advanced melanoma: a meta-analysis of clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nivolumab-Induced Sarcoid-Like Granulomatous Reaction in a Patient With Advanced Melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary sarcoid-like granulomatosis induced by nivolumab.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A Review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus: A case report

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Programmed cell death-1 pathway inhibitors in genitourinary malignancies: specific side-effects and their management

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring and Management of Immune-Related Adverse Events Associated With Programmed Cell Death Protein-1 Axis Inhibitors in Lung Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vedolizumab: a novel treatment for ipilimumab-induced colitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Checkpoint immunotherapy: good for cancer therapy, bad for rheumatic diseases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Managing immune checkpoint-inhibitor-induced severe autoimmune-like hepatitis by liver-directed topical steroids

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New-onset third-degree atrioventricular block because of autoimmune-induced myositis under treatment with anti-programmed cell death-1 (nivolumab) for metastatic melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheumatic and musculoskeletal immune-related adverse events due to immune checkpoint inhibitors: A systematic review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammatory arthritis due to immune checkpoint inhibitors: challenges in diagnosis and treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preserved Renal-Allograft Function and the PD-1 Pathway Inhibitor Nivolumab.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review: Immune-Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastrointestinal and Hepatic Complications of Immune Checkpoint Inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune Checkpoint Blockade and Hematopoietic Stem Cell Transplant

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular Toxicities Associated with Cancer Immunotherapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histopathologic Features of Colitis Due to Immunotherapy With Anti-PD-1 Antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypophysitis: Nursing Management of Immune-Related Adverse Events

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer Immunotherapy: An Evidence-Based Overview and Implications for Practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How I treat autoimmune hemolytic anemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular Complications Associated With Novel Cancer Immunotherapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrombotic thrombocytopenic purpura

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of red blood cell autoantibodies following treatment with checkpoint inhibitors: a new class of anti-neoplastic, immunotherapeutic agents associated with immune dysregulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of Pneumonitis Associated with Programmed Cell Death 1 Inhibitors in Cancer Patients: A Meta-analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune Checkpoint Inhibitors: An Innovation in Immunotherapy for the Treatment and Management of Patients with Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hallmarks of response to immune checkpoint blockade

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute coronary syndrome as a possible immune-related adverse event in a lung cancer patient achieving a complete response to anti-PD-1 immune checkpoint antibody.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of treatment-related mortality in cancer patients treated with ipilimumab: A systematic review and meta-analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful use of equine anti-thymocyte globulin (ATGAM) for fulminant myocarditis secondary to nivolumab therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progressive and Reversible Conduction Disease With Checkpoint Inhibitors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of arthritis induced by checkpoint inhibitors with tocilizumab: a case series.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pembrolizumab induced encephalopathy: a review of neurological toxicities with immune checkpoint inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival After Fulminant Myocarditis Induced by Immune-Checkpoint Inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurological Complications Associated With Anti-Programmed Death 1 (PD-1) Antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of checkpoint inhibitors for cancer treatment: strategies for patient monitoring and management of immune-mediated adverse events

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Outcomes in Patients With Metastatic Lung Cancer Treated With PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and Efficacy Implications of Discontinuing Combination Ipilimumab and Nivolumab in Advanced Melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease: A Systematic Review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/29442540

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2017.77.6385

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6481621&resulttype=core&format=json

14 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50015039&oldid=1545567171"